|
42. Targeting autophagy triggers apoptosis and complements the action of venetoclax in chronic lymphocytic leukemia cellsDamjan Avsec, Alma Tana Jakoš Djordjevič, Maša Kandušer, Helena Podgornik, Matevž Škerget, Irena Mlinarič-Raščan, 2021, original scientific article Keywords: chronic lymphocytic leukemia, autophagy, AMPK/ULK1, venetoclax, drug resistance, targeted therapy Full text (file, 5,50 MB) This document has more files! More... |
43. In vitro ciliotoxicity and cytotoxicity testing of repeated chronic exposure to topical nasal formulations for safety studiesLarisa Tratnjek, Nadica Sibinovska, Katja Kristan, Mateja Erdani-Kreft, 2021, original scientific article Keywords: nasal drug formulations, mucociliary clearance, cytotoxicity, ciliary beat frequency, nasal in vitro model, repeated exposure, ciliotoxicity, ultrastructural analysis, drug safety Full text (file, 6,01 MB) This document has more files! More... |
44. Polymorphism in gene for ABCC2 transporter predicts methotrexate drug survival in patients with psoriasisJasna Grželj, Maruška Marovt, Pij B. Marko, Irena Mlinarič-Raščan, Tanja Gmeiner, Alenka Šmid, 2021, original scientific article Keywords: psoriasis, drug survival, methotrexate, pharmacogenetics Full text (file, 865,71 KB) This document has more files! More... |
45. Ustekinumab dosing individualization in Crohn's disease guided by a population pharmacokinetic-pharmacodynamic modelJurij Zdovc, Jurij Hanžel, Borut Štabuc, Tomaž Vovk, Barbara Ostanek, David Drobne, Iztok Grabnar, 2021, original scientific article Keywords: ustekinumab, inflammatory bowel disease, fecal calprotectin, pharmacokinetics-pharmacodynamics, therapeutic drug monitoring Full text (file, 1,20 MB) This document has more files! More... |
46. COVID-19 vaccines safety tracking (CoVaST)Abanoub Riad, Janja Marc, Miloslav Klugar, 2021, original scientific article Keywords: cohort studies, cross-sectional studies, COVID-19, drug-related side effects, adverse reactions, health personnel, mass vaccination, prevalence Full text (file, 560,94 KB) This document has more files! More... |
47. Predicting drug release rate of implantable matrices and better understanding of the underlying mechanisms through experimental design and artificial neural network-based modellingErnő Benkő, Ilija German Ilić, Katalin Kristó, Géza Regdon, Ildikó Csóka, Klára Pintye-Hódi, Stanko Srčič, Tamás Sovány, 2022, original scientific article Keywords: drug–excipient interaction, polymers, non-degradable polymers, matrix tablet, controlled release, design of experiments, artificial neural networks Full text (file, 3,15 MB) This document has more files! More... |
48. Epstein-Barr virus-encoded BILF1 orthologues from porcine lymphotropic herpesviruses display common molecular functionalityMaša Mavri, Valentina Kubale, Daniel P. Depledge, Jianmin Zuo, Christene A. Huang, Judith Breuer, Milka Vrecl, Michael A. Jarvis, Eva Jarc Jovičić, Toni Petan, Bernhard Ehlers, Mette Marie Rosenkilde, Katja Spiess, 2022, original scientific article Keywords: Epstein-Barr virus, porcine lymphotropic herpesviruses (PLHV), BILF1, G protein signaling, MHC class I, drug target, post-transplant lymphoproliferative disease, in-vivo model Full text (file, 6,64 MB) This document has more files! More... |
49. Applicability of RPMI 2650 and Calu-3 cell models for evaluation of nasal formulationsNadica Sibinovska, Simon Žakelj, Jurij Trontelj, Katja Kristan, 2022, original scientific article Keywords: RPMI 2650 cell line, Calu-3 cell line, nasal drug formulations, nasal epithelium, drug permeability Full text (file, 689,95 KB) This document has more files! More... |
50. Polymorphisms in GNMT and DNMT3b are associated with methotrexate treatment outcome in plaque psoriasisJasna Grželj, Irena Mlinarič-Raščan, Pij B. Marko, Maruška Marovt, Tanja Gmeiner, Alenka Šmid, 2021, original scientific article Keywords: methotrexate, pharmacogenetics, psoriasis, methionine cycle, drug response, hepatotoxicity Full text (file, 2,77 MB) This document has more files! More... |